EUVIMEDEUVIMED entdecken
Open Access

Relationship of Mild to Moderate Impairment of Left Ventricular Ejection Fraction With Fatal Ventricular Arrhythmic Events in Cardiac Sarcoidosis

Yuka Akama iD, Yudai Fujimoto iD, Yuya Matsue iD, Daichi Maeda iD, Kenji Yoshioka, Taishi Dotare iD, Tsutomu Sunayama, Takeru Nabeta iD, Yoshihisa Naruse iD, Takeshi Kitai iD, Tatsunori Taniguchi iD, Shuntaro Sato iD und 4 weitere

Journal of the American Heart Association · 2024

DOI: 10.1161/jaha.123.032047 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, 2024. Verfasst von Yuka Akama und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Biology and Medicine Juntendo University Graduate School of Medicine Tokyo Japan. Hauptthemen laut MEDLINE: Sarcoidosis, Defibrillators, Implantable, Myocarditis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Current guidelines recommend placing an implantable cardiac defibrillator for patients with cardiac sarcoidosis and a severely impaired left ventricular ejection fraction (LVEF) of ≤35%. In this study, we determined the association between mild or moderate LVEF impairment and fatal ventricular arrhythmic event (FVAE). Methods and Results We retrospectively analyzed 401 patients with cardiac sarcoidosis without sustained ventricular arrhythmia at diagnosis. The primary end point was an FVAE, defined as the combined endpoint of documented ventricular tachycardia or ventricular fibrillation and sudden cardiac death. Two cutoff points for LVEF were used: a sex‐specific lower threshold of normal range of LVEF (52% for men and 54% for women) and an LVEF of 35%, which is used in the current guidelines. During a median follow‐up of 3.2 years, 58 FVAEs were observed, and the 5‐ and 10‐year estimated incidences of FVAEs were 16.8% and 23.0%, respectively. All patients were classified into 3 groups according to LVEF: impaired LVEF group, mild to moderate impairment of LVEF group, and maintained LVEF group. Multivariable competing risk analysis showed that both the impaired LVEF group (hazard ratio [HR], 3.24 [95% CI, 1.49–7.04]) and the mild to moderate impairment of LVEF group (HR, 2.16 [95% CI, 1.04–4.46]) were associated with a higher incidence of FVAEs than the maintained LVEF group after adjustment for covariates.

Conclusions

Patients with cardiac sarcoidosis are at a high risk of FVAEs, regardless of documented ventricular arrhythmia at the time of diagnosis. In patients with cardiac sarcoidosis, mild to moderate impairment of LVEF is associated with FVAEs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcoidosisDefibrillators, ImplantableMyocarditisMaleHumansFemaleVentricular Function, LeftStroke VolumeRetrospective StudiesArrhythmias, CardiacDeath, Sudden, Cardiac

Stichwörter der Autor:innen

cardiac sarcoidosisrisk stratificationsudden cardiac deathventricular arrhythmia

Autor:innen und Institutionen

  • Department of Cardiovascular Biology and Medicine Juntendo University Graduate School of Medicine Tokyo Japan.
  • Department of Cardiology Kameda Medical Center Chiba Japan.
  • Department of Cardiovascular Medicine Kitasato University School of Medicine Sagamihara Japan.
  • Division of Cardiology, Internal Medicine III Hamamatsu University School of Medicine Hamamatsu Japan.
  • Department of Cardiovascular Medicine National Cerebral and Cardiovascular Center Osaka Japan.
  • Department of Cardiovascular Medicine Osaka University Graduate School of Medicine Osaka Japan.

ORCID-Profile: Yuka Akama, Yudai Fujimoto, Yuya Matsue, Daichi Maeda, Taishi Dotare, Takeru Nabeta, Yoshihisa Naruse, Takeshi Kitai, Tatsunori Taniguchi, Shuntaro Sato, Hidekazu Tanaka, Takahiro Okumura, Yuichi Baba, Tohru Minamino

Zitieren

APA

Akama, Y., Fujimoto, Y., Matsue, Y., Maeda, D., Yoshioka, K., Dotare, T., Sunayama, T., Nabeta, T., Naruse, Y., Kitai, T., Taniguchi, T., Sato, S., Tanaka, H., Okumura, T., Baba, Y., & Minamino, T. (2024). Relationship of Mild to Moderate Impairment of Left Ventricular Ejection Fraction With Fatal Ventricular Arrhythmic Events in Cardiac Sarcoidosis. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.032047

Vancouver

Akama Y, Fujimoto Y, Matsue Y, Maeda D, Yoshioka K, Dotare T, et al. Relationship of Mild to Moderate Impairment of Left Ventricular Ejection Fraction With Fatal Ventricular Arrhythmic Events in Cardiac Sarcoidosis. Journal of the American Heart Association. 2024. doi:10.1161/jaha.123.032047

BibTeX
@article{Akama2024,
  author = {Akama, Yuka and Fujimoto, Yudai and Matsue, Yuya and Maeda, Daichi and Yoshioka, Kenji and Dotare, Taishi and Sunayama, Tsutomu and Nabeta, Takeru and Naruse, Yoshihisa and Kitai, Takeshi and Taniguchi, Tatsunori and Sato, Shuntaro and Tanaka, Hidekazu and Okumura, Takahiro and Baba, Yuichi and Minamino, Tohru},
  title = {Relationship of Mild to Moderate Impairment of Left Ventricular Ejection Fraction With Fatal Ventricular Arrhythmic Events in Cardiac Sarcoidosis},
  journal = {Journal of the American Heart Association},
  year = {2024},
  doi = {10.1161/jaha.123.032047}
}
Kostenlos starten →